丝裂霉素C的眼毒性。 - Suppr

Suppr

超能文献

Ocular toxicity of mitomycin-C.

作者信息

Hardten D R, Samuelson T W

机构信息

University of Minnesota, Minneapolis, USA.

出版信息

Int Ophthalmol Clin. 1999 Spring;39(2):79-90. doi: 10.1097/00004397-199903920-00007.

DOI:10.1097/00004397-199903920-00007

PMID:10343926

Abstract

摘要

相似文献

Ocular toxicity of mitomycin-C.

Int Ophthalmol Clin. 1999 Spring;39(2):79-90. doi: 10.1097/00004397-199903920-00007.

Mitomycin: clinical applications in ophthalmic practice.

Drugs. 2006;66(3):321-40. doi: 10.2165/00003495-200666030-00005.

Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

Am J Ophthalmol. 1998 Mar;125(3):416-7. doi: 10.1016/s0002-9394(99)80165-2.

Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.

Br J Ophthalmol. 2006 Jul;90(7):807-9. doi: 10.1136/bjo.2006.092734.

Intraoperative mitomycin in primary pterygium excision.

Ophthalmology. 1998 Jan;105(1):3-4.

[Necrotizing scleritis after pterygium surgery using mitomycin C].

J Fr Ophtalmol. 2012 Jan;35(1):74-5. doi: 10.1016/j.jfo.2011.03.019. Epub 2011 Sep 8.

Herpes keratitis in a patient undergoing treatment with topical mitomycin C.

Cornea. 2011 Apr;30(4):466-7. doi: 10.1097/ICO.0b013e3181f7f345.

Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.

Cornea. 2002 Oct;21(7):715-7. doi: 10.1097/00003226-200210000-00017.

Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

Am J Ophthalmol. 1997 Sep;124(3):303-11. doi: 10.1016/s0002-9394(14)70822-0.

Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.

Ophthalmic Surg Lasers. 2002 Jan-Feb;33(1):58-61.

引用本文的文献

Retinal Toxicity Secondary to Suprachoroidal Migration of Mitomycin-C.

J Vitreoretin Dis. 2024 Aug 31;8(6):744-748. doi: 10.1177/24741264241269533. eCollection 2024 Nov-Dec.

SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon's Capsule Fibroblasts.

J Ophthalmol. 2020 Feb 10;2020:5703286. doi: 10.1155/2020/5703286. eCollection 2020.

Effects of intraoperative steroid injection on the outcome of pterygium surgery.

Eye (Lond). 2013 Aug;27(8):906-14. doi: 10.1038/eye.2013.142. Epub 2013 Jul 26.

In vitro and in vivo comparison of two suprachoroidal shunts.

Invest Ophthalmol Vis Sci. 2013 Aug 13;54(8):5416-23. doi: 10.1167/iovs.13-11853.

Complications of management in primary acquired melanosis with atypia.

Br J Ophthalmol. 2007 Nov;91(11):1567-8. doi: 10.1136/bjo.2007.116491.

Mitomycin C for pterygium: long term evaluation.

Br J Ophthalmol. 2004 Nov;88(11):1425-8. doi: 10.1136/bjo.2003.039891.

Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment.

Br J Ophthalmol. 2000 Sep;84(9):973-8. doi: 10.1136/bjo.84.9.973.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Ocular toxicity of mitomycin-C.

Int Ophthalmol Clin. 1999 Spring;39(2):79-90. doi: 10.1097/00004397-199903920-00007.

Mitomycin: clinical applications in ophthalmic practice.

Drugs. 2006;66(3):321-40. doi: 10.2165/00003495-200666030-00005.

Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

Am J Ophthalmol. 1998 Mar;125(3):416-7. doi: 10.1016/s0002-9394(99)80165-2.

Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.

Br J Ophthalmol. 2006 Jul;90(7):807-9. doi: 10.1136/bjo.2006.092734.

Intraoperative mitomycin in primary pterygium excision.

Ophthalmology. 1998 Jan;105(1):3-4.

[Necrotizing scleritis after pterygium surgery using mitomycin C].

J Fr Ophtalmol. 2012 Jan;35(1):74-5. doi: 10.1016/j.jfo.2011.03.019. Epub 2011 Sep 8.

Herpes keratitis in a patient undergoing treatment with topical mitomycin C.

Cornea. 2011 Apr;30(4):466-7. doi: 10.1097/ICO.0b013e3181f7f345.

Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.

Cornea. 2002 Oct;21(7):715-7. doi: 10.1097/00003226-200210000-00017.

Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.

Am J Ophthalmol. 1997 Sep;124(3):303-11. doi: 10.1016/s0002-9394(14)70822-0.

Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.

Ophthalmic Surg Lasers. 2002 Jan-Feb;33(1):58-61.

引用本文的文献

Retinal Toxicity Secondary to Suprachoroidal Migration of Mitomycin-C.

J Vitreoretin Dis. 2024 Aug 31;8(6):744-748. doi: 10.1177/24741264241269533. eCollection 2024 Nov-Dec.

SPARC Levels Modulate the Capacity of Mitomycin to Inhibit the Proliferation of Human Tenon's Capsule Fibroblasts.

J Ophthalmol. 2020 Feb 10;2020:5703286. doi: 10.1155/2020/5703286. eCollection 2020.

Effects of intraoperative steroid injection on the outcome of pterygium surgery.

Eye (Lond). 2013 Aug;27(8):906-14. doi: 10.1038/eye.2013.142. Epub 2013 Jul 26.

In vitro and in vivo comparison of two suprachoroidal shunts.

Invest Ophthalmol Vis Sci. 2013 Aug 13;54(8):5416-23. doi: 10.1167/iovs.13-11853.

Complications of management in primary acquired melanosis with atypia.

Br J Ophthalmol. 2007 Nov;91(11):1567-8. doi: 10.1136/bjo.2007.116491.

Mitomycin C for pterygium: long term evaluation.

Br J Ophthalmol. 2004 Nov;88(11):1425-8. doi: 10.1136/bjo.2003.039891.

Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment.

Br J Ophthalmol. 2000 Sep;84(9):973-8. doi: 10.1136/bjo.84.9.973.